Profound Medical (PROF) Return on Capital Employed (2025 - 2026)
Profound Medical's (PROF) quarterly Return on Capital Employed came in at 58.76% in Q1 2026, up 157.0% year-on-year from 22.86% in Q1 2025, and up 23.35% quarter-over-quarter from 76.66% in Q4 2025.
Profound Medical (PROF) Return on Capital Employed (2025 - 2026) Analysis & Trends
Profound Medical's Return on Capital Employed history runs 2 years deep, the most recent figure standing at 58.76% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 157.0% year-over-year to 58.76% in Q1 2026; TTM through Mar 2026 was 58.76%, a 157.0% increase from a year earlier, with the FY2025 full-year figure at 60.87%, up 457.0% from the prior year.
- Return on Capital Employed improved to 58.76% in Q1 2026 per PROF's latest filing, from 76.66% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 58.76% in Q1 2026 and bottomed at 117.15% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 129.08 Bn | 126.21 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 68.52 Bn | 67.07 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 24.24% |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.88 Bn | 1.98 Bn | 9.30% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.37 Bn | 21.25 Bn | 2.07 Bn | 8.38% |
| 10 | Profound Medical | 267.51 Mn | 217.22 Mn | 3.83 Mn | -58.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.76% |
| Dec 31, 2025 | -76.66% |
| Sep 30, 2025 | -117.15% |
| Jun 30, 2025 | -85.41% |
| Mar 31, 2025 | -60.33% |